| P2093 | author name string | Kiyoyuki Furuse | |
| | Masaaki Kawahara | |
| | Tomoya Kawaguchi | |
| | Kiyonobu Ueno | |
| | Kyoichi Okishio | |
| | Shinji Atagi | |
| | Nobuyuki Naka | |
| | Mitsumasa Ogawara | |
| | Shigeto Hosoe | |
| | Tessei Tsuchiyama | |
| | Yuuji Takemoto | |
| P2860 | cites work | Phase II study of paclitaxel, ifosfamide, and cisplatin as second-line treatment in relapsed small-cell lung cancer | Q31781043 |
| | Paclitaxel and carboplatin in the treatment of small-cell lung cancer patients resistant to cyclophosphamide, doxorubicin, and etoposide: a non-cross-resistant schedule | Q33328110 |
| | Topotecan versus cyclophosphamide, doxorubicin, and vincristine for the treatment of recurrent small-cell lung cancer | Q33328193 |
| | Prolonged administration of oral etoposide in patients with relapsed or refractory small-cell lung cancer: a phase II trial | Q33395941 |
| | Combination of irinotecan and etoposide for treatment of refractory or relapsed small-cell lung cancer | Q33503969 |
| | Predictors of survival following relapse or progression of small cell lung cancer. Southwest Oncology Group Study 8605 report and analysis of recurrent disease data base | Q36771904 |
| | Evaluation of high-dose etoposide combined with cisplatin for treating relapsed small cell lung cancer | Q43833331 |
| | Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer | Q43850218 |
| | CPT-11: a new derivative of camptothecin for the treatment of refractory or relapsed small-cell lung cancer | Q67492629 |
| | Effects of carboplatin in combination with other anticancer agents on human leukemia cell lines | Q70552396 |
| | Dose-intensive weekly chemotherapy for treatment of relapsed small-cell lung cancer | Q71975353 |
| | Second-line chemotherapy for relapsed small cell lung cancer | Q73583159 |
| P433 | issue | 3 | |
| P921 | main subject | irinotecan | Q412197 |
| | carboplatin | Q415588 |
| | lung cancer | Q47912 |
| P304 | page(s) | 319-323 | |
| P577 | publication date | 2002-09-01 | |
| P1433 | published in | Lung Cancer | Q641464 |
| P1476 | title | Phase II study of weekly irinotecan and carboplatin for refractory or relapsed small-cell lung cancer | |
| P478 | volume | 37 | |